MiniMed Group, Inc. (MMED)

NASDAQ:MMED

MMED

MiniMed Group, Inc.

RESEARCH TOOLSreports

Want to see MMED full AI Analyst Report?

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

37 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MMED Analyst Ratings

Strong Buy

11 Buy

1 Hold

0 Sell

Based on 12 analysts giving stock ratings to

MiniMed

Group, Inc.

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MMED Stock 12 Month Forecast

Average Price Target

$20.92

▲(44.86% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for MiniMed Group, Inc. in the last 3 months. The average price target is $20.92 with a high forecast of $27.00 and a low forecast of $14.00. The average price target represents a 44.86% change from the last price of $14.44.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"13":"$13","28":"$28","16.75":"$16.75","20.5":"$20.5","24.25":"$24.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20.9175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$20.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[13,16.75,20.5,24.25,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.48,15.443076923076923,16.406153846153845,17.369230769230768,18.332307692307694,19.295384615384616,20.25846153846154,21.22153846153846,22.184615384615384,23.14769230769231,24.11076923076923,25.073846153846155,26.036923076923078,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.48,14.975192307692309,15.470384615384615,15.965576923076924,16.46076923076923,16.955961538461537,17.451153846153847,17.946346153846154,18.441538461538464,18.93673076923077,19.431923076923077,19.927115384615384,20.422307692307694,{"y":20.9175,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.48,14.443076923076923,14.406153846153847,14.36923076923077,14.332307692307692,14.295384615384616,14.258461538461539,14.221538461538461,14.184615384615384,14.147692307692308,14.11076923076923,14.073846153846153,14.036923076923078,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.49,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.49,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.48,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$27.00

Average Price Target$20.92

Lowest Price Target$14.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Anthony Petrone

Mizuho Securities

$21

Buy

45.43%

Upside

Reiterated

04/13/26

Mizuho Securities Remains a Buy on MiniMed Group, Inc. (MMED)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$19

Buy

31.58%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at Morgan StanleyMiniMed initiated with an Overweight at Morgan Stanley

Steven Lichtman

William Blair

$14

Buy

-3.05%

Downside

Initiated

03/31/26

MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair

Pito Chickering

Deutsche Bank

$20

Buy

38.50%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank

Matt Miksic

Barclays

$26

Buy

80.06%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Travis Steed

Bank of America Securities

$27

Buy

86.98%

Upside

Initiated

03/31/26

MiniMed: Capturing Post–Spin-Off Growth Inflection With Integrated Pump/CGM Platform and Attractive Valuation

Joanne Wuensch

Citi

$23

Buy

59.28%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at CitiMiniMed initiated with a Buy at Citi

Daniel Markowitz CFA

Evercore ISI

$20

Buy

38.50%

Upside

Initiated

03/31/26

MiniMed initiated with an Outperform at Evercore ISIMiniMed initiated with an Outperform at Evercore ISI

Larry Biegelsen

Wells Fargo

$26

Buy

80.06%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at Wells FargoMiniMed initiated with an Overweight at Wells Fargo

David Roman

Goldman Sachs

$14.01

Buy

-2.98%

Downside

Initiated

03/31/26

MiniMed initiated with a Buy at Goldman SachsMiniMed initiated with a Buy at Goldman Sachs

Matthew O'Brien

Piper Sandler

$16

Hold

10.80%

Upside

Initiated

03/31/26

Balancing Franchise Strength with Execution Risks: Why MiniMed Merits a Hold Rating

Marie Thibault

BTIG

$25

Buy

73.13%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at BTIGMiniMed initiated with a Buy at BTIG

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Anthony Petrone

Mizuho Securities

$21

Buy

45.43%

Upside

Reiterated

04/13/26

Mizuho Securities Remains a Buy on MiniMed Group, Inc. (MMED)

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$19

Buy

31.58%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at Morgan StanleyMiniMed initiated with an Overweight at Morgan Stanley

Steven Lichtman

William Blair

$14

Buy

-3.05%

Downside

Initiated

03/31/26

MiniMed initiated with an Outperform at William BlairMiniMed initiated with an Outperform at William Blair

Pito Chickering

Deutsche Bank

$20

Buy

38.50%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at Deutsche BankMiniMed initiated with a Buy at Deutsche Bank

Matt Miksic

Barclays

$26

Buy

80.06%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at BarclaysMiniMed initiated with an Overweight at Barclays

Travis Steed

Bank of America Securities

$27

Buy

86.98%

Upside

Initiated

03/31/26

MiniMed: Capturing Post–Spin-Off Growth Inflection With Integrated Pump/CGM Platform and Attractive Valuation

Joanne Wuensch

Citi

$23

Buy

59.28%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at CitiMiniMed initiated with a Buy at Citi

Daniel Markowitz CFA

Evercore ISI

$20

Buy

38.50%

Upside

Initiated

03/31/26

MiniMed initiated with an Outperform at Evercore ISIMiniMed initiated with an Outperform at Evercore ISI

Larry Biegelsen

Wells Fargo

$26

Buy

80.06%

Upside

Initiated

03/31/26

MiniMed initiated with an Overweight at Wells FargoMiniMed initiated with an Overweight at Wells Fargo

David Roman

Goldman Sachs

$14.01

Buy

-2.98%

Downside

Initiated

03/31/26

MiniMed initiated with a Buy at Goldman SachsMiniMed initiated with a Buy at Goldman Sachs

Matthew O'Brien

Piper Sandler

$16

Hold

10.80%

Upside

Initiated

03/31/26

Balancing Franchise Strength with Execution Risks: Why MiniMed Merits a Hold Rating

Marie Thibault

BTIG

$25

Buy

73.13%

Upside

Initiated

03/31/26

MiniMed initiated with a Buy at BTIGMiniMed initiated with a Buy at BTIG

Stocks with the Highest Top Analyst Consensus in the General Sector

xxx

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MiniMed Group, Inc.

3 Months

xxx

Success Rate

1/2 ratings generated profit

Average Return

-1.45%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -1.45% per trade.

1 Year

Anthony PetroneMizuho Securities

Success Rate

1/2 ratings generated profit

Average Return

-1.45%

Copying Anthony Petrone's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.45% per trade.

2 Years

xxx

Success Rate

1/2 ratings generated profit

Average Return

-1.45%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.45% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MMED Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MMED has received 12 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. MMED average Analyst price target in the past 3 months is 20.92.

Each month's total comprises the sum of three months' worth of ratings.

MMED Financial Forecast

No data currently available

MMED Earnings Forecast

Currently, no earnings data available.

No data currently available

MMED Sales Forecast

Currently, no sales data available.

MMED Stock Forecast FAQ

What is MMED’s average 12-month price target, according to analysts?

Based on analyst ratings, MiniMed Group, Inc.’s 12-month average price target is 20.92.

What is MMED’s upside potential, based on the analysts’ average price target?

MiniMed Group, Inc. has 44.86% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MMED a Buy, Sell or Hold?

MiniMed Group, Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.

What is MiniMed Group, Inc.’s price target?

The average price target for MiniMed Group, Inc. is 20.92. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $27.00 ,the lowest forecast is $14.00. The average price target represents 44.86% Increase from the current price of $14.44.

What do analysts say about MiniMed Group, Inc.?

MiniMed Group, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of MMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

MiniMed Group, Inc. (MMED) Stock Forecast & Price Target

MMED Analyst Ratings

MMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering MiniMed Group, Inc.

MMED Analyst Recommendation Trends

MMED Financial Forecast

MMED Earnings Forecast

MMED Sales Forecast

MMED Stock Forecast FAQ

Detailed List of Analyst Forecasts